1. Cardio- and Vasoprotective Effects of Quinacrine in an In Vivo Rat Model of Myocardial Ischemia/Reperfusion Injury.
- Author
-
Sonin DL, Pochkaeva EI, Papayan GV, Minasian SM, Mukhametdinova DV, Zaytseva EA, Mochalov DA, Petrishchev NN, and Galagudza MM
- Subjects
- Animals, Rats, Male, Disease Models, Animal, Capillary Permeability drug effects, Myocardial Infarction drug therapy, Myocardial Infarction pathology, Myocardium pathology, Quinacrine pharmacology, Quinacrine therapeutic use, Myocardial Reperfusion Injury drug therapy, Myocardial Reperfusion Injury pathology, Rats, Wistar, Cardiotonic Agents pharmacology, Cardiotonic Agents therapeutic use
- Abstract
This study aimed to investigate the cardioprotective effect of quinacrine in an in vivo model of myocardial ischemia/reperfusion injury. A 30-min regional myocardial ischemia followed by a 2-h reperfusion was modeled in anesthetized Wistar rats. Starting at the last minute of ischemia and during the first 9 min of reperfusion the rats in the control (n=8) and experimental (n=9) groups were injected with 0.9% NaCl and quinacrine solution (5 mg/kg), respectively. The area at risk and infarct size were evaluated by "double staining" with Evans blue and triphenyltetrazolium chloride. To assess vascular permeability in the area at risk zone, indocyanine green (ICG) and thioflavin S (ThS) were injected intravenously at the 90th and 120th minutes of reperfusion, respectively, to assess the no-reflow zone. The images of ICG and ThS fluorescence in transverse sections of rat hearts were obtained using a FLUM multispectral fluorescence organoscope. HR tended to decrease by 13% after intravenous administration of quinacrine and then recovered within 50 min. Quinacrine reduced the size of the necrotic zone (p=0.01), vascular permeability in the necrosis region, and the no-reflow area (p=0.027); at the same time, the area at risk did not significantly differ between the groups. Intravenous administration of quinacrine at the beginning of reperfusion of the rat myocardium reduces no-reflow phenomenon and infarct size., (© 2024. Springer Science+Business Media, LLC, part of Springer Nature.)
- Published
- 2024
- Full Text
- View/download PDF